Safety and Efficacy Trial of Imexon Plus DTIC in Advanced Malignant Melanoma

This study has been completed.
Sponsor:
Information provided by:
AmpliMed Corporation
ClinicalTrials.gov Identifier:
NCT00327600
First received: May 17, 2006
Last updated: September 14, 2010
Last verified: September 2010
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: December 2007
  Primary Completion Date: January 2007 (Final data collection date for primary outcome measure)
Publications: